1 Research and Development Expenses: Implications for Profitability Measurement and Valuation Aswath Damodaran Stern School of Business 44 West Fourth Street New York, NY
2 Abstract Most valuation models begin with a measure of accounting earnings to arrive at cash flow estimates. When using accounting earnings, we implicitly assume that the income is obtained by netting out only those expenses that are operating expenses, i.e., expenses designed to generate revenues in the current period. Expenses that are intended to provide benefits over multiple periods are assumed to be considered as capital expenditures, and these expenses are depreciated or amortized over multiple periods. In addition, when computing profitability measures such as return on equity and capital, we stick with this assumption that operating income measures income generated by assets in place. In this paper, we examine the accounting treatment of research and development expenses, and the effects of the treatment on operating income, capital and profitability. We argue that research and development expenses should be treated as tax-deductible capital expenditures, for purposes of valuation, and this can have significant effects on operating income, capital and expected growth measures for firms with substantial research expenses.
3 The operating income for a firm is estimated by netting out all operating expenses from revenues. When valuing a firm, we usually begin with after-tax operating income and then reduce it by the reinvestment needs of the firm. The reinvestment needs cover any investments that the firm needs to make to generate future growth, and include both capital expenditures and working capital investments. The distinction between operating and capital expenditures is critical for tax calculations, and is important in determining both the amount of capital on a firm's books and how its profitability is measured. In this paper, we will consider the accounting treatment of research and development expenses as operating expenses, and argue that it is not appropriate to do so, at least for valuation purposes. Considering research and development expenses as capital expenses will have profound effects on estimates of cash flow and growth in valuation, and in determining earnings multiples for purposes of relative valuation. Operating and Capital Expenditures Accounting statements classify all expenses into three categories - operating expenses, financing expenses and capital expenses. Operating expenses are expenses that, at least in theory, provide benefits only for the current period; the cost of labor and materials expended to create products which are sold in the current period would be a good example. Financing expenses are expenses arising from the non-equity financing used to raise capital for the business; the most common example is interest expenses. Capital expenses are expenses that are expected to generate benefits over multiple periods; for instance, the cost of buying land and buildings is treated as a capital expense. Operating expenses are subtracted from revenues in the current period to arrive at a
4 measure of operating earnings from the firm. Financing expenses are subtracted from operating earnings to estimate earnings to equity investors or net income. Capital expenses are written off over their useful life (in terms of generating benefits) as depreciation or amortization. The distinction between operating and financing expenses may not be significant for tax purposes, since both are tax deductible, but the distinction between operating and capital expenses affects taxes. Operating expenses are deductible in the period in which they are made, whereas capital expenses are written off over the useful life of the investment. The distinction also matters for purposes of asset and capital measurement. Operating expenses create no assets and affect capital only indirectly through retained earnings. Capital expenses, on the other hand, create assets and consequently affect capital as well. The Accounting Treatment of Research and Development Expenses Capital expenditures are defined as those expenditures that are likely to create benefits over multiple periods. By this definition, investments in land, plant and long term equipment are capital investments, but so is research and development. In fact, a reasonable argument can be made that research and development expenses (R&D) are more long term than investments in physical plant and equipment at many firms, especially those in the pharmaceutical and high technology sectors. Thus, it follows that R&D expenses should be treated as capital expenditures. In reality, however, accounting standards in the United States require the treatment of R&D as operating expenses. In this
5 section, we will examine the consequences of this rule for earnings and capital measurement at firms with substantial research expenses. Accounting Rules Governing R&D Expenses Prior to 1975, companies in the United States were allowed to capitalize R&D expenses. Accounting rule SFAS 2, which has governed the treatment of research and development expenses since 1975, requires that all R&D expenses be expensed in the period incurred. The only exception is for contract R&D done for unrelated entities. The rationale for treating forcing firms to expense R&D seems to lie in the belief that the benefits are uncertain, and occur only when the research leads to a commercial product. Consequently, it is argued that the asset created by research is not one that can be used by the firm to borrow money. This, to us, sounds like a dangerous path to follow. Using this reasoning, there are a number of capital investments, especially those in riskier businesses, which would qualify for expensing, simply because they have no liquidation value and have uncertain cash flows. Outside the United States, IAS 9 also requires the expensing of research cost but allows for the capitalization of development expenses. Development costs are defined to include all costs involved in turning research into commercial products or services. In the UK and Canada, firms are permitted, but not required, to capitalize development costs as the research gets closer to commercial exploitation. In general, though, most companies in most countries expense research and development expenses.
6 Consequences for Earnings Measurement The treatment of R&D as an operating expense has the immediate effect of lowering both operating and net income. The tax deductibility of these expenses buffers the impact somewhat, and the net income and after-tax operating income are both reduced by the following: After-tax Effect of R&D expense on earnings = R&D Expenses (1 - marginal tax rate) For companies that end up with negative earnings as a consequence of research expenses, the after-tax effect will be even larger because the tax benefit has to be deferred until future periods. The treatment of research expenditures as operating expenses also implies that research expenditures create no assets. Thus, patents that emerge from internal research will not be shown as assets on the balance sheet. In contrast, patents acquired from third parties can be treated as assets. This contradiction in the treatment of patents has given rise to game playing on the part of firms with substantial research expenditures R&D Partnerships In an R&D partnership, a group of investors creates a partnership, which agrees to cover the entire research and development expense for a firm. In return, the partnership gets the rights to any products developed by the partnership. In most cases, however, the firm preserves the right to purchase the partnership or license the product some time in the future. From the perspective of the firm, this arrangement essentially means that R&D
7 expenses are eliminated, because the revenues from the partnership cover the expenses entirely. For partners in the partnership, there is the potential at least of a large payoff if the research pays off in the form of commercial products. This arrangement can clearly be misused by firms that want to move research expenses off the books, and borrow funds to finance this research. SFAS 68 requires that there be an actual transfer of risk from the firm to the partnership. In other words, the firm should not be under any obligation to return cash received from the partnership, if the research does not pay off. A Financial Analysis of Research and Development Expenses Research and development expenses are designed to generate future growth and should be treated as capital expenditures. In this section, we will consider how to reclassify research expenses and the consequences for reported earnings, capital and profitability. A Reclassification of R&D Expenses The first step in the reclassification of R&D expenses is to remove it from operating expenses and show it as a capital expenditure. The steps that follow are not as simple. First, the reclassified R&D expense becomes a capital expense and is no longer expensed. Second, capital expenses create assets, and R&D is not an exception. The after-tax R&D expense has to be cumulated over time to create an asset that we can loosely call the research asset. Third, like other assets, the research asset can lose value
8 over time and hence may have to be amortized over its life. The amortization that is generated is not tax deductible, but it will affect operating income. The movement of R&D from the operating expense to the capital expenditure column can have profound implications for profitability measures and for projections of cash flows into the future. The Effect on Assets and Capital When we treat R&D expenses as capital expenditures, we have to maintain consistency and treat cumulated R&D expenses as an asset. The simplest way to do this is to cumulate the after-tax research and development expenses 1 over time and create a research asset. This asset will then be amortized over time, with both the length of the amortization period and the amortization schedule being determined by the nature of the research expenses, and the estimated time until there is a payoff to the investment. Thus, for pharmaceutical companies where FDA approval can take as long as a decade, the research asset will be amortized over an extended period. In contrast, for high technology firms where the payoff is much sooner, the research asset will have to be amortized over a shorter period. 1 The reason we cumulate after-tax research and development expenses is because R&D expenses are tax deductible. Amortizing the entire R&D expense will generate amortization that is too large, relative to the capital investment from R&D.
9 If the research is on clearly identified products, there is a more direct approach to amortization. Research expenses should be completely written off when one of two scenarios occur. One is if the product is found not to be viable, and is abandoned. The research expense on that product should then be written off. The other is if the firm decides to invest in producing the product commercially, in which case the research expense on the asset has to be written off and replaced with the physical assets created by the investment. The capital and assets of a firm will increase when R&D expenses are capitalized, but the extent of the change will depend upon how long the company has been in existence and its cumulated R&D over that period. Thus, firms which have been in existence for a long period and have invested substantially in R&D over that period will see a much bigger change in their capital than firms that have been around for short period. The amortization schedule can also make a difference, since the cumulated research asset gets reduced by the amortization each year. Thus, the research asset for a firm that amortizes its research over five years, can be estimated by cumulating R&D expenses over the last five years 2 and reducing this cumulated amount by the amortization on these expenses. 2 There might have been R&D expenses prior to the five years, but they will have no material impact on the current value of the research asset since they would have been entirely amortized by now.
10 Is there a way to estimate the market value of the research asset? The value of the patents generated by the research can be estimated using real option models, but basic research will be difficult to value. Illustration 1: Effect on Capital and Equity of Reclassifying R& D Expenses: Boeing To value the research asset for Boeing, we first need to make an assumption about the amortizable life of the research asset. In the case of Boeing, the products are new and improved airplanes that have long commercial lives. Consequently, we use a ten-year life for Boeing s research asset, and assume that any research expenses are amortized uniformally in the ten years after the expense is incurred. The following table values the research asset at Boeing, based upon the R&D expenses at Boeing over the last 10 years (including the current year): Year R&D Unamortized Portion Unamortized Value 1988 $ $ $ $ $ $ $1, $ $1, $ $1, $ $1, $1,193
11 1995 $1, $1, $1, $1, $1, $1,924 Capitalized Value of R& D Expenses = $8,587 Note that with the assumption of straight line amortization, only 1/10 th of the research expense in 1988 remains amortized, 2/10 th of the expense in 1989 and so on The value of the research asset at Boeing is a substantial $8.587 billion. This research asset augments the assets, equity and capital of the firm. Thus, the adjusted book value of aasets, equity and capital at Boeing can be estimated as follows: Equity Capital Book Value $14,353 $22,319 + Research Asset $8,587 $8,587 = Adjusted Book Value $21,540 $30,907 Firms with significant research expenditures will have much higher values for assets, capital and equity once research expenditures are capitalized. The Effect on Operating and Net Income Will treating research and development expenses as capital expenditures increase or decrease operating income? The effect depends upon the trend in research expenditures and amortization of previous research expenses. To illustrate, the following table lays out operating income, with the conventional treatment of R&D expenses, and operating income, with R&D treated as a capital expenditure: Conventional Treatment of R&D R&D as Capital Expenditures
12 Revenues - Operating Expenses - R&D = Operating Income - Taxes = Operating Income after taxes Revenues - Operating Expenses - Amortization of Research Asset = Operating Income - Taxes (based on conventional treatment) = Operating Income after taxes Whether operating income increases or decreases when R&D is reclassified will depend upon whether the amortization of the research asset is greater than or less than the R&D expense in the current year. For high growth firms, where R&D expenses tend to grow substantially over time, the reclassification will lead to an increase in operating income. As these firms mature, and R&D expenses level off, the operating income may well decrease. Illustration 2: Effect of R&D Reclassification on Operating and Net Income In the following analysis, we will examine the effects of reclassifying R&D expenses as capital expenditures on operating income and net income at Boeing. Operating Income $1,078 + Research and Development Expenses $1,924 - Amortization of Research Asset $1,272 = Adjusted Operating Income $1,731
13 We also compute the effect on after-tax operating income of capitalizing R&D expenses as capital expenditures. Operating Income (1-t) $701 + Research and Development Expenses $1,924 - Amortization of Research Asset $1,272 = Adjusted After-tax Operating Income $1,353 Note that this estimate of the after-tax operating income is different from that obtained by multiplying the adjusted operating income by (1- tax rate). This reflects the tax benefit earned by the firm because the revenue code allows the entire R&D expense to be deducted for tax purposes, unlike its treatment of other capital expenditures. The magnitude of the tax benefit to the firm from expensing R&D, as opposed to capitalizing it, can be computed as follows: Adjusted After-tax Operating Income = $ 1,353 million Adjusted Operating Income (1- tax rate) = $ 1,125 million Tax Benefit = $ 208 million Finally, we look at the effect on net income of reclassifying research and development expenses as capital expenditures. Net Income $721 + R & D expenses $1,924 - Amortization of Research Asset $1,272
14 = Adjusted Net Income $1,384 Again, the adjusted net income reflects the tax benefit created by the tax treatment of research and development expenditures. The Effects on Profitability The reclassification of R&D from an operating to a capital expense has a significant impact on both the earnings and the capital estimates for a firm. Thus, the return on equity and capital for a firm will change when the reclassification is made. Will the return on equity and capital increase or decrease when R&D is recategorized? The return on capital after the recategorization of R&D will look as follows: ROC R&D Adjusted = EBIT(1-t)+R&D Expense - Amortization of Research Asset (BV of Capital + Research Asset) The effect of reclassifying R&D expenses will depend upon two factors: - The magnitude of the R&D expense is in the current year relative to R&D expenses in prior years: When the current R&D expense is significantly higher than expenses in previous years the returns on equity and capital will increase on the recategorization. (The increase in operating income in proportional terms will be greater than the increase in capital invested). When the current R&D expense is similar to or smaller than R&D expenses in previous years, the returns on equity and capital will drop when R&D expenses are recategorized.
15 - The level of the unadjusted return on capital: Firms with high unadjusted returns on capital are much more likely to see drops in the return when research and development is classified as a capital expenditure. This is because the net research expense (After-tax R&D expense - R&D amortization) as a percent of the research asset is likely to be lower than the unadjusted return on capital and thus pull the return down. The effects on return on equity are similar, though the effects will be magnified because the proportional impact on net income and book value of equity of reclassifying R&D expenses is likely to be larger. Illustration 3: Effects of R&D Reclassification on Profitability Measures To compute the effects of reclassifying research and development expenses on profitability measures, we first compute the return on capital using both adjusted and unadjusted measures of operating income and capital: Boeing Boeing (Adjusted) After-tax Operating Income $701 $1,353 BV of Capital - Beginning $21,547 $30,039 BV of Capital - Ending $20,363 $30,907 BV of Capital - Average $20,955 $30,473 ROC (based on average) 3.34% 4.44% ROC (based on beginning) 3.25% 4.51%
16 Note that the both beginning and ending capital are increased by the assessed value of the research asset. The net effect of reclassifying R&D expenses is an increase in the return on capital. The effect on return on equity can also be similarly assessed. To do so, we compute the adjusted net income and book value of equity: Return Ratios Boeing Boeing (Adjusted) Net Income $732 $1,384 BV of Equity- Beginning $13,502 $21,437 BV of Equity- Ending $12,953 $22,940 BV of Equity - Average $13,228 $22,188 ROE (based on average) 5.53% 6.24% ROE (based on beginning) 5.42% 6.46% Note again that the return on equity increases when net income and book value of equity are adjusted to reflect the recapitalization of R&D expenses. The Effect on Cash Flows Reclassifying R&D expenses as capital expenses does not affect current cash flows since it has no tax effect. The following table clearly indicates this: Cash Flow with Conventional Treatment of R&D EBIT(1-t) + Depreciation - Cap Ex Cash Flow with R&D treated as a Capital Expenditure EBIT (1-t) + R& D Expense - R & D Amortization
17 - Change in Working Capital = Free Cash Flow to Firm = Adjusted After-tax Operating Income + R & D Amortization + Depreciation - Cap Ex - R & D Expense - Change in Working Capital = Free Cash Flow to Firm Note that the taxes are still based upon the unadjusted operating income, and that reclassifying R&D for analysis purposes does not affect tax calculations. Working through the expanded calculation, we arrive at the same free cash flow to the firm. The same analysis applies when we look at free cash flow to equity. If there is no effect on the free cash flows, why bother with the reclassification in the first place? By separating out R&D expenses from other operating expenses, we get a cleaner picture of what a firm is actually earning on its assets in place, and how much it is investing for future growth. This becomes critical when we project these cash flows into the future. The Effects on Expected Growth The real effects of recategorizing R&D show up when we compute the expected growth in operating income and cash flows. Note that the growth in operating income can be written in terms of the reinvestment rate and the return on capital earned on investments. Growth EBIT = Reinvestment Rate * Return on Capital
18 Where, Reinvestment Rate = (Cap Ex - Depreciation + Change in Working Capital)/ EBIT (1-t) Return on Capital = EBIT (1-t) / Capital Invested Firms whose primary capital expenditures are research and development expenses often have anemic reinvestment rates, when R&D is classified as an operating expense and thus look like they should have really low expected growth rates. The return on capital is also misestimated for the same reasons. When R&D is reclassified as a capital expenditure, the reinvestment rate and return on capital will be affected: Cap Ex - Depreciation WC+R&D + Expense - Amortization of Research Asset Reinvestment Rate R&D Adjusted = EBIT(1- t)+r&d Expense - Amortization of Research Asset ROC R&D Adjusted = EBIT(1-t)+R&D Expense - Amortization of Research Asset (BV of Capital + Research Asset) The growth in operating income will then reflect these changes. Generally, rapidly growing firms that increase research expenditures proportionately will have much higher reinvestment rates and lower return on capital after the adjustment. This will then result in higher growth in operating income. The reclassification of research expenses also allows us to discriminate between growth firms that are investing in research and growth firms that are not. When R&D expenses are treated as operating expenses, the latter will look much better on all measures of profitability from operating margins to returns on capital. Treating R&D expenses as capital expenditures allows us to bring both groups of firms to an equal
19 footing in terms of profitability measures, while giving firms that are investing in research the benefits of higher growth and potentially higher value. Illustration 4: Effects on Reinvestment Rate and Expected Growth In the following table, we compute the reinvestment rate, return on capital and expected growth rate for Boeing using unadjusted numbers and estimates adjusted to reflect the capitalization of research expenses: Unadjusted With R&D capitalized Net Cap Ex $37 $689 EBIT(1-t) $701 $1,353 Reinvestment Rate 5.28% 50.94% Return on Capital 3.25% 4.51% Expected Growth 0.17% 2.29% Note that the reinvestment rate increases dramatically when we count the research expenses as capital expenditures. This reflects the fact the research expenses at Boeing have been increasing over time. The Effect on Discounted Cash Flow Value While reclassifying R&D expenses as capital expenditures might have no effect on current cash flows, it has profound effects on valuation for the following reasons: - The estimates of expected growth can be tied much more closely to whether and how much a firm is investing for that growth (in R&D) and how effective it is in converting the R&D into profits (through the return on capital). Thus, it forces analysts to consider not just the magnitude of research expenditures but the quality of these investments as well.
20 - In valuation we often assume that operating margins and returns on capital at firms converge on industry averages as we move through time. If these industry averages are computed using the conventional definition of R&D as an operating expense, there is no reason to assume that firms will move towards these averages. If, on the other hand, the industry averages are computed with R&D reclassified as a capital expenditure, it can be argued that competitive pressures will push margins towards convergence. - When computing terminal value, it is critical that assumptions about growth be consistent with assumptions about reinvestment rates and returns on capital. This is impossible to do as long as R&D expenses are treated as operating expenses. When they are reclassified as capital expenditures, the reinvestment rate can be computed and it will include research and development expenses. Illustration 5: Effects of R& D Reclassification on Value In the following illustration, we value Boeing twice, once with the conventional treatment of R&D as an expense and once with R&D expenses capitalized. We first present the valuation of Boeing, using the reported after-tax operating income. We begin by applying the fundamental growth rate (from the reinvestment rate and return on capital estimated in illustration 4) to revenues. Since 1997 was a year in which Boeing reported significantly lower operating income than in prior year, we projected that the after-tax operating margin would recover to the average level that Boeing enjoyed between 1992 and The improvement to the target margin of 4.12% is assumed to occur linearly
21 from the current level over the next 3 years. After year 3, we assume that the company is in stable growth. For the other components, we assume that capital expenditures and depreciation grow at the same rate as revenues, and that non-cash working capital remains 5% of revenues over the entire period. Base Terminal Year Revenues $45,800 $45,879 $45,957 $46,036 $46,115 Operating Margin 1.53% 2.39% 3.26% 4.12% 4.12% EBIT(1-t) $701 $1,098 $1,497 $1,898 $1,901 + Deprec n & Amort $ 1,356 $ 1,359 $ 1,361 $ 1,363 - Capital Exp $ (1,393) $ (1,396) $ (1,398) $ (1,401) - Change in WC $ 4 $ 4 $ 4 $ 4 FCFF $1,057 $1,456 $1,856 $1,860 Terminal Value $ 20,529 Present Value $ 968 $ 1,221 $ 17,177 Value of Firm = $ 19,365 Growth Rate in Revenues = 0.17% Target after-tax Operating Margin = 4.12% Working Capital as % of Revenues = 5% Cost of Capital = 9.23% The growth rate used is computed based upon the reinvestment rate and return on capital computed in illustration 4. We also valued Boeing, with R&D expenses re-categorized as capital expenses. This affects every aspect of the valuation:
22 - The operating income used is the adjusted operating income estimated in illustration 2, with R&D expenses capitalized and amortized. - The target after-tax operating margin in stable growth is the pre-r&d margin estimated for Boeing to be 5.55%, instead of 4.12%. - The depreciation is augmented by the amortization of R&D expenses over time. We assume that both the R&D expenses and the amortization increase at the revenue growth rate over this period. - The capital expenditures include the estimated R&D expenses over time The following table summarizes the valuation of Boeing with these inputs: Base Terminal Year Revenues $45, $ 46, $ 47, $ 49, $ 50, Operating Margin 2.95% 3.82% 4.68% 5.55% 5.55% EBIT(1-t) $1,353 $ 1, $ 2, $ 2, $ 2, Deprec'n & Amort $2,626 $ 2,686 $ 2,748 $ 2,811 $ 2,875 - Capital Exp ($3,315) $ (3,391) $ (3,469) $ (3,548) $ (3,630) - Change in WC $ 53 $ 54 $ 55 $ 56 FCFF $ 1,031 $ 1,469 $ 1,926 $ 1,970 Terminal Value $ 28,410 Present Value $ 944 $ 1,231 $ 23,278 Value of Firm $ 25,453 Growth Rate in Revenues = 2.29% Target after-tax Operating Margin 5.55% Working Capital as % of Revenues 5% Cost of Capital = 9.23%
23 Note that the expected growth rate of 2.29% in revenues is estimated based upon the adjusted reinvestment rate and return on capital for Boeing. Overall, the value of Boeing as a firm increases by about $ 6 billion. The effects on valuation of capitalizing R&D expenses tend to be greatest when the growth rate is computed from the reinvestment rate and the return on capital. When the growth rate is an exogenous variable, analysts often adjust the growth rate to reflect the opportunities created by research. In these cases, the effects on value tend to be unpredictable, and value can be much higher than or lower than the true value, depending upon whether the growth rate is over or under estimated. The Effects on Earnings Multiples When research and development expenses are reclassified, there will be significant shifts in some of the multiples commonly used in valuation. All earnings multiples will have to be re-estimated, since reclassifying R&D as a capital expenditure changes both operating income and net income. Thus, price-earnings ratios, PEG ratios, Value/EBIT and Value/EBITDA multiples will all be affected. The book value ratios will also change since the book value of capital and equity will both shift when R&D is reclassified as an asset. To the extent that multiples are used to compare how companies within a sector are valued, there are some who argue that there should be no change in the relative valuations and rankings when R&D is reclassified. This is clearly not true since R&D expenses vary across companies, depending upon their relative size, growth and stage in the life cycle. As a general rule, the earnings multiples of smaller, higher growth companies will decrease relative to the earnings multiples of larger, more mature firms.
24 Illustration 6: Effects of R& D Reclassification on Multiples In the following table, we summarize both earnings and book value multiples for Boeing, when R&D expenses are capitalized, and compare them to the conventional measures: Unadjusted Adjusted PE Ratio Value/EBITDA Price/Book Value of Equity Value/ Book Value of Capital Note that the adjustment reduces the PE ratio, because the net income is much higher when R&D expenses are capitalized for Boeing. This reflects the fact that Boeing research expenses have been increasing over time, and the expense thus outweighs the amortization charge. There is a similar effect on the Value/EBITDA multiple, but this effect will occur for all firms with research expenses, since the amortization of the expense is added back. Finally, the addition of the research asset to the book value of equity and capital reduces the market to book ratios for all firms with research expenses, though the magnitude of the impact will vary depending upon how large the expenses are relative to the size of the firm. Conclusion Accounting rules clearly specify that operating expenses are expenses designed to generate income in the current period, whereas capital expenditures are
25 designed to provide benefits over multiple periods. The current treatment of research and development expenses are operating expenses seems to violate this distinction. In this paper, we have argued that R&D expenses are in fact capital expenditures and should therefore not be shown as part of operating expenses. To be consistent, we also argue that research and development expenses create a research asset that has to be amortized over time. The effects of reclassifying R&D expenses on operating income and profitability ratios will vary across companies. In firms where R&D expenses have been increasing rapidly over time, reclassifying R&D can push up operating income significantly and can make return on capital a much higher number. In mature firms, where R&D expenses have been stable over time, the return on capital may decrease when R&D is reclassified.
Dealing with Operating Leases in Valuation Aswath Damodaran Stern School of Business 44 West Fourth Street New York, NY 10012 email@example.com Abstract Most firm valuation models start with the after-tax
II. Estimating Cash Flows DCF Valuation Aswath Damodaran 61 Steps in Cash Flow Estimation Estimate the current earnings of the firm If looking at cash flows to equity, look at earnings after interest expenses
Estimating Cash Flows DCF Valuation 1 Steps in Cash Flow Estimation Estimate the current earnings of the firm If looking at cash flows to equity, look at earnings after interest expenses - i.e. net income
Financial Statement Analysis! The raw data for investing Aswath Damodaran! 1! Questions we would like answered! Assets Liabilities What are the assets in place? How valuable are these assets? How risky
From Reported to Actual Earnings Firmʼs history Comparable Firms Operating leases - Convert into debt - Adjust operating income R&D Expenses - Convert into asset - Adjust operating income Normalize Earnings
0 CHAPTER 15 FIRM VALUATION: COST OF CAPITAL AND APV APPROACHES In the last two chapters, we examined two approaches to valuing the equity in the firm -- the dividend discount model and the FCFE valuation
Leases, Debt and Value Aswath Damodaran Stern School of Business 44 West Fourth Street New York, NY 10012 firstname.lastname@example.org April 2009 Abstract When analyzing or the value of a firm, there are three
TYPES OF FINANCIAL RATIOS In the previous articles we discussed how to invest in the stock market and unit trusts. When investing in the stock market an investor should have a clear understanding about
Finding the Right Financing Mix: The Capital Structure Decision Aswath Damodaran 1 First Principles Invest in projects that yield a return greater than the minimum acceptable hurdle rate. The hurdle rate
What Do Short-Term Liquidity Ratios Measure? What Is Working Capital? HOCK international - 2004 1 HOCK international - 2004 2 How Is the Current Ratio Calculated? How Is the Quick Ratio Calculated? HOCK
03-Seidman.qxd 5/15/04 11:52 AM Page 41 3 An Introduction to Business Financial Statements In this chapter, we build on the basic knowledge of how businesses are financed by looking at how firms organize
CASH FLOW STATEMENT On the statement, cash flows are segregated based on source: Operating activities: involve the cash effects of transactions that enter into the determination of net income. Investing
Employee Options, Restricted Stock and Value 1 Basic Proposition on Options Any options issued by a firm, whether to management or employees or to investors (convertibles and warrants) create claims on
Acquisition Valuation Aswath Damodaran Aswath Damodaran 1 Issues in Acquisition Valuation Acquisition valuations are complex, because the valuation often involved issues like synergy and control, which
Homework Solutions - Lecture 4 1. Estimate fundamental growth in EBIT for Nike based on the firm s reinvestment rate and ROC in the most recent year. Be sure to incorporate any necessary adjustments made
Value Enhancement: EVA and CFROI Aswath Damodaran 1 Alternative Approaches to Value Enhancement Maximize a variable that is correlated with the value of the firm. There are several choices for such a variable.
Private Company Valuation Aswath Damodaran Aswath Damodaran 179 Process of Valuing Private Companies Choosing the right model Valuing the Firm versus Valuing Equity Steady State, Two-Stage or Three-Stage
FINAL REVIEW It s over Beta measures market risk Top-down: Regress stock returns against market return Slope coefficient is the beta Bottom up: 1. Determine businesses that your firm operates in 2. Get
1 Valuing Companies with intangible assets September 2009 Aswath Damodaran Stern School of Business email@example.com 2 Valuing Companies with intangible assets As we move from manufacturing to service
NIKE Case Study Professor Corwin This case study includes several problems related to the valuation of Nike. We will work through these problems throughout the course to demonstrate some of the most important
FIN 301 Class Notes Chapter 17: Financial Statement Analysis INTRODUCTION Financial ratio: is a relationship between different accounting items that tells something about the firm s activities. Purpose
The Debt-Equity Trade Off: The Capital Structure Decision Aswath Damodaran Stern School of Business Aswath Damodaran 1 First Principles Invest in projects that yield a return greater than the minimum acceptable
CHAPTER OUTLINE Spotlight: J&S Construction Company (http://www.jsconstruction.com) 1 The Lemonade Kids Financial statement (accounting statements) reports of a firm s financial performance and resources,
Chapter 7: Capital Structure: An Overview of the Financing Decision 1. Income bonds are similar to preferred stock in several ways. Payment of interest on income bonds depends on the availability of sufficient
CFAspace Provided by APF CFA Level II Equity Investments Free Cash Flow Valuation Part I CFA Lecturer: Hillary Wang Content Free cash flow to the firm, free cash flow to equity Ownership perspective implicit
Topic Mapping 1 Transaction Analysis Understand the effect of various types of transactions on the accounting equation, accounting journal and accounting ledger. Concepts and Skills Accounting Equation
Leases, Debt and Value Aswath Damodaran When analyzing or the value of a firm, there are three basic questions that we need to address: How much is the firm generating as earnings? How much has been invested
Estimating Growth Aswath Damodaran Aswath Damodaran 1 Ways of Estimating Growth in Earnings Look at the past The historical growth in earnings per share is usually a good starting point for growth estimation
The Free Cashflow to Equity Model Aswath Damodaran Aswath Damodaran 1 Sony: Background on Japanese firms Japanese firms have proved to be among the most difficult to value for several reasons: The earnings
Long-lived Assets 2014 Level I Financial Reporting and Analysis IFT Notes for the CFA exam Contents 1. Introduction... 3 2. Acquisition of Long-Lived Assets... 3 3. Depreciation and Amortization of Long-Lived
Fair Value: Fact or Opinion Aswath Damodaran Aswath Damodaran 1 Fair value is in the eyes of the beholder Don t measure fair value by precision: As uncertainty about an asset s cash flows increase, the
HHIF Lecture Series: Financial Statement Analysis Alexander Remorov Based on the Materials by Daanish Afzal University of Toronto November 5, 2010 Alexander Remorov, Daanish Afzal (University of Toronto)
Chapter 4: Liquor Store Business Valuation In this section, we will utilize three approaches to valuing a liquor store. These approaches are the: (1) cost (asset based), (2) market, and (3) income approach.
HEALTHCARE FINANCE: AN INTRODUCTION TO ACCOUNTING AND FINANCIAL MANAGEMENT Online Appendix A Financial Ratios INTRODUCTION In Chapter 17, we indicated that ratio analysis is a technique commonly used to
Discounted Cash Flow Valuation: Basics Aswath Damodaran Aswath Damodaran 1 Discounted Cashflow Valuation: Basis for Approach Value = t=n CF t t =1(1+r) t where CF t is the cash flow in period t, r is the
Net Capital Expenditures Net capital expenditures represent the difference between capital expenditures and depreciation. Depreciation is a cash inflow that pays for some or a lot (or sometimes all of)
CASH FLOW STATEMENT & BALANCE SHEET GUIDE The Agriculture Development Council requires the submission of a cash flow statement and balance sheet that provide annual financial projections for the business
Guide to Financial Statements Study Guide Overview (Topic 1) Three major financial statements: The Income Statement The Balance Sheet The Cash Flow Statement Objectives: Explain the underlying equation
Equity Analysis and Capital Structure A New Venture s Perspective 1 Venture s Capital Structure ASSETS Short- term Assets Cash A/R Inventories Long- term Assets Plant and Equipment Intellectual Property
Free Cash Flow Overview When you re valuing a company with a DCF analysis, you need to calculate their Free Cash Flow (FCF) to figure out what they re worth. While Free Cash Flow is simple in theory, in
Introduction to Financial Statements NOTES TO ACCOMPANY VIDEOS These notes are intended to supplement the videos on ASimpleModel.com. They are not to be used as stand alone study aids, and are not written
Interim Group Report 0106/2016 Key financial performance indicators for the Lenzing Group will be described here in detail. For the most part, they are derived from the Lenzing Group s condensed consolidated
EVALUATING CAPITAL INVESTMENTS IN AGRIBUSINESS Technological advancements impact the agribusiness industry in a very irregular fashion. Given the difficulties associated with predicting the arrival and/or
Investing on hope? Small Cap and Growth Investing! Aswath Damodaran Aswath Damodaran! 1! Who is a growth investor?! The Conventional definition: An investor who buys high price earnings ratio stocks or
Financial Terms & Calculations So much about business and its management requires knowledge and information as to financial measurements. Unfortunately these key terms and ratios are often misunderstood
C H A P T E R 1 0 STATEMENT OF CASH FLOWS AND WORKING CAPITAL ANALYSIS I N T R O D U C T I O N Historically, profit-oriented businesses have used the accrual basis of accounting in which the income statement,
Measuring Financial Performance: A Critical Key to Managing Risk Dr. Laurence M. Crane Director of Education and Training National Crop Insurance Services, Inc. The essence of managing risk is making good
Management Accounting 337 Statement of Cash Flow Cash is obviously an important asset to all, both individually and in business. A shortage or lack of cash may mean an inability to purchase needed inventory
Relative valuation and Technical Analysis Relative vs. fundamental valuation The DCF model is a method of fundamental valuation. Value of equity is the present value of future cash flows. Ignores the current
CASH FLOW STATEMENT (AND FINANCIAL STATEMENT) - At the most fundamental level, firms do two different things: (i) They generate cash (ii) They spend it. Cash is generated by selling a product, an asset
Value Multiples Aswath Damodaran Aswath Damodaran 1 Value/Earnings and Value/Cashflow Ratios While Price earnings ratios look at the market value of equity relative to earnings to equity investors, Value
Financial Reporting and Analysis Chapter 13 Solutions Income Tax Reporting Exercises Exercises E13-1. Determining current taxes payable (AICPA adapted) The amount of current income tax liability that would
Value of Equity and Per Share Value when there are options and warrants outstanding Aswath Damodaran 1 Equity Value and Per Share Value: A Test Assume that you have done an equity valuation of Microsoft.
www.bdo.ca Assurance and accounting Comparison Series Issue 19: Joint Arrangements and Associates Both and are principle based frameworks, and from a conceptual standpoint many of the general principles
Finding the Right Financing Mix: The Capital Structure Decision Aswath Damodaran Stern School of Business Aswath Damodaran 1 First Principles Invest in projects that yield a return greater than the minimum
Valuation Aswath Damodaran Home Page: http://www.stern.nyu.edu/~adamodar Email: firstname.lastname@example.org This presentation is under seminars. Aswath Damodaran 1 Some Initial Thoughts " One hundred thousand
Finance Master Winter 2015/16 Jprof. Narly Dwarkasing University of Bonn, IFS Chapter 2 Outline 2.1 Firms Disclosure of Financial Information 2.2 The Balance Sheet 2.3 The Income Statement 2.4 The Statement
Today s Agenda DFR1 and Quiz 3 recap Net Capital Expenditures Working Capital Dividends Estimating Cash Flows Net Capital expenditures Net capital expenditures = capital expenditures - depreciation Depreciation
FINANCIAL INTRODUCTION In earlier sections you calculated your cost of goods sold, overhead expenses and capital cost in order to help you determine the sales price of your product. In your business plan,
CHAPTER 9 Long-Lived Assets SYNOPSIS In this chapter, the author discusses (1) accounting for the acquisition, use, and disposal of long-lived assets, and (2) management's incentives for selecting accounting
Management Accounting 217 Capital Budgeting Decisions Tools In many businesses, growth is a major factor to business success. Substantial growth in sales may eventually means a need to expand plant capacity.
Valuation multiples A reading prepared by Pamela Peterson rake James Madison University Table of Contents Introduction... 1 Understanding the use of multiples... 1 Identifying the comparables... 1 Choosing
Current and Non-Current Assets as Part of the Regulatory Asset Base. (The Return to Working Capital: Australia Post) R.R.Officer and S.R Bishop 1 4 th October 2007 Overview Initially, the task was to examine
Discounted Cash Flow: Application and Misapplication Hal Heaton, PhD The Income Approach to Valuation In the income approach (specifically the discounted cash flow approach) value is determined by discounting
Chapter 2 Financial Statement and Cash Flow Analysis Answers to Concept Review Questions 1. What role do the FASB and SEC play with regard to GAAP? The FASB is a nongovernmental, professional standards
Company Valuation Assignment 1 Group Members: Sammy Keene, Teemu Mikkonen, Jacub Jankowski, Jordan Dick Owner [Type the company name] Contents 1. Abstract... 2 2. Introduction... 3 3. Stock Performance...
Financial ratio analysis A reading prepared by Pamela Peterson Drake O U T L I N E 1. Introduction 2. Liquidity ratios 3. Profitability ratios and activity ratios 4. Financial leverage ratios 5. Shareholder
Financial Accounting Financial Statement Analysis Dr. Charles W. Mulford Scheller College of Business Georgia Institute of Technology Atlanta, GA 30332-0520 (404) 894-4395 email@example.com Financial
Page 1 ACC 255 FINAL EXAM REVIEW PACKET (NEW MATERIAL) Complete these sample exam problems/objective questions and check your answers with the solutions at the end of the review file and identify where
Off-Balance Sheet Financing Techniques (1) Leases Firms which have noncancelable operating leases have de facto debt. The following adjustment procedure is appropriate. Calculate Present Value of future
1 Valuing Young, Start-up and Growth Companies: Estimation Issues and Valuation Challenges Aswath Damodaran Stern School of Business, New York University firstname.lastname@example.org May 2009 2 Valuing Young,
BA 351 CORPORATE FINANCE John R. Graham Adapted from S. Viswanathan LECTURE 5 LEASING FUQUA SCHOOL OF BUSINESS DUKE UNIVERSITY 1 Leasing has long been an important alternative to buying an asset. In this
1 LOOKING FORWARD: ESTIMATING GROWTH The value of a firm is the present value of expected future cash flows generated by the firm. The most critical input in valuation, especially for high growth firms,
VALUATIONS I Financial Metrics, Ratios, & Comparables Analysis Fall 2015 Comp Week 6 CODE: COMPS Timeline Date Topic 9/10/15 Introduction to Finance 9/17/15 Qualitative Analysis: SWOT and Porter s Five
Chapter 7 7-1 Income bonds do share some characteristics with preferred stock. The primary difference is that interest paid on income bonds is tax deductible while preferred dividends are not. Income bondholders
NACM Central Region Credit Conference 2012 Analyzing the Statement of Cash Flows John A. Jaeger, CCE Manager Credit & Accounts Receivable Follett Higher Education Group 1 1 Analyzing the Statement of Cash
What's Your Business Worth? What you see isn't usually what you get - or want! "How much is my business worth?" and "How do I know for sure?" and "Why should I care? After all, I have no intention of selling
Lecture: Week V 1 Issues in Capital Budgeting What is Capital Budgeting? The process of making and managing expenditures on long-lived assets. Allocating available capital amongst investment opportunities.
Accounting MacIC Beginner Question Bank Here are the 5 most important Accounting concepts you need to know: The 3 financial statements and what each one means How the 3 statements link together and how
1 VALUING FINANCIAL SERVICE FIRMS Banks, insurance companies and other financial service firms pose a particular challenge for an analyst attempting to value them for two reasons. The first is the nature
Understanding Cash Flow Statements 2014 Level I Financial Reporting and Analysis IFT Notes for the CFA exam Contents 1. Introduction... 3 2. Components and Format of the Cash Flow Statement... 3 3. The
FAIR VALUE ACCOUNTING: VISIONARY THINKING OR OXYMORON? Aswath Damodaran Three big questions about fair value accounting Why fair value accounting? What is fair value? What are the first principles that